Mraz Amerine & Associates’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
NAMI
BIP
ETC
Mraz Amerine & Associates's ABEV Position: Q2 2026 in Review
Mraz Amerine & Associates reduced its Ambev (ABEV) stake by 0.17% in Q2 2026, selling an estimated $3.81K and leaving 705,089 shares worth $2.21M. The position accounts for 0.32% of the portfolio, ranked #56.
Mraz Amerine & Associates first reported a position in ABEV in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.73M in Q2 2023. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.
- Mraz Amerine & Associates held 705,089 shares of Ambev worth $2.21M as of Q2 2026.
- Mraz Amerine & Associates sold 1,220 Ambev shares in Q2 2026, an estimated $3.81K.
- Ambev made up 0.32% of Mraz Amerine & Associates's portfolio in Q2 2026, its #56 holding.
- Mraz Amerine & Associates first reported a position in Ambev in Q2 2021 and has held it in 21 quarters since.
- Mraz Amerine & Associates's Ambev position peaked at $2.73M in Q2 2023.
- 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.
Based on Mraz Amerine & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.